Stock data
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX) reported revenue of US$100.25M and net income of -US$73.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$100.25M | US$55.54M | -US$71.68M | -US$73.20M | — |
| 2024 | US$65.12M | US$35.89M | -US$45.25M | -US$54.76M | — |
| 2023 | US$11.99M | US$6.31M | -US$35.85M | -US$44.10M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$32.01M | -US$23.40M | — |
| 2026-03-31 | US$27.63M | -US$21.89M | — |
| 2025-12-31 | US$32.12M | -US$13.47M | — |
| 2025-09-30 | US$27.25M | -US$14.21M | — |
| 2025-06-30 | US$23.24M | -US$16.87M | — |
| 2025-03-31 | US$17.64M | -US$28.66M | — |
| 2024-12-31 | US$20.44M | -US$18.11M | — |
| 2024-09-30 | US$16.70M | -US$9.74M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.